Eugenio Mercuri Selected Research

eteplirsen

3/2024	Survival among patients receiving eteplirsen for up to 8 years for the treatment of Duchenne muscular dystrophy and contextualization with natural history controls.
1/2022	A Combined Prospective and Retrospective Comparison of Long-Term Functional Outcomes Suggests Delayed Loss of Ambulation and Pulmonary Decline with Long-Term Eteplirsen Treatment.
1/2021	Comparison of Long-term Ambulatory Function in Patients with Duchenne Muscular Dystrophy Treated with Eteplirsen and Matched Natural History Controls.
1/2021	Open-Label Evaluation of Eteplirsen in Patients with Duchenne Muscular Dystrophy Amenable to Exon 51 Skipping: PROMOVI Trial.
1/2018	Genetic therapies for inherited neuromuscular disorders.
2/2016	Longitudinal effect of eteplirsen versus historical control on ambulation in Duchenne muscular dystrophy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Eugenio Mercuri Research Topics

Disease

54	Spinal Muscular Atrophy (Progressive Muscular Atrophy) 05/2024 - 02/2005
44	Duchenne Muscular Dystrophy (Muscular Dystrophy, Becker) 04/2024 - 03/2007
14	Muscular Diseases (Myopathy) 01/2022 - 12/2004
10	Disease Progression 08/2023 - 12/2013
9	Muscular Dystrophies (Muscular Dystrophy) 04/2024 - 02/2006
6	Scleroatonic muscular dystrophy 12/2013 - 04/2005
5	Spinal Muscular Atrophies of Childhood (Werdnig Hoffman Disease) 01/2023 - 07/2008
5	Limb-Girdle Muscular Dystrophies (Limb-Girdle Muscular Dystrophy) 01/2020 - 02/2005
4	Vomiting 04/2024 - 01/2017
4	Cardiomyopathies (Cardiomyopathy) 01/2024 - 06/2012
4	Fever (Fevers) 01/2022 - 01/2017
4	Inborn Genetic Diseases (Disease, Hereditary) 01/2021 - 10/2014
4	Bethlem myopathy 12/2013 - 04/2005
3	Infections 01/2024 - 12/2016
3	Congenital Structural Myopathies (Centronuclear Myopathy) 09/2022 - 03/2013
3	Nemaline Myopathies (Nemaline Myopathy) 04/2021 - 12/2004
3	Contracture 04/2021 - 02/2005
2	Body Weight (Weight, Body) 04/2023 - 11/2021
2	Cerebral Palsy (Spastic Diplegia) 12/2022 - 11/2014
2	Central Core Myopathy (Central Core Disease) 01/2022 - 12/2004
2	Minicore Myopathy with External Ophthalmoplegia 01/2022 - 12/2004
2	Neuromuscular Diseases (Neuromuscular Disease) 11/2021 - 06/2020
2	Headache (Headaches) 01/2021 - 01/2019
2	Retinopathy of Prematurity (Retrolental Fibroplasia) 01/2020 - 01/2018
2	Limb-girdle muscular dystrophy type 2A 01/2020 - 02/2005
2	Nasopharyngitis 01/2019 - 01/2017
2	Scoliosis 01/2019 - 01/2014
2	Craniosynostoses (Craniosynostosis) 01/2017 - 12/2007
2	Rare Diseases (Rare Disease) 10/2016 - 01/2016
2	Seizures (Absence Seizure) 12/2012 - 05/2012
2	Muscle Weakness 08/2012 - 06/2012
2	Emery-Dreifuss Muscular Dystrophy (Scapuloperoneal Muscular Dystrophy) 06/2012 - 02/2010
2	Cysts 11/2008 - 02/2006
2	Vision Disorders (Hemeralopia) 02/2008 - 09/2003
1	Liver Diseases (Liver Disease) 01/2024
1	Motor Skills Disorders (Motor Skills Disorder) 07/2022
1	Joint Instability (Joint Laxity) 07/2022
1	Respiratory Insufficiency (Respiratory Failure) 06/2022
1	Spinal muscular atrophy with respiratory distress 1 06/2022
1	Arthralgia (Joint Pain) 01/2022
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2022
1	Pneumonia (Pneumonitis) 01/2022
1	Aphthous Stomatitis (Aphthous Ulcer) 01/2022
1	Urinary Tract Infections (Urinary Tract Infection) 01/2022
1	Exanthema (Rash) 01/2022
1	Coronavirus Infections 12/2021
1	Post-Dural Puncture Headache 11/2021
1	Eye Diseases (Eye Disease) 01/2021
1	Biotinidase Deficiency (Multiple Carboxylase Deficiency, Late Onset) 06/2020
1	Multiple Carboxylase Deficiency (Deficiency, Multiple Carboxylase) 06/2020

Drug/Important Bio-Agent (IBA)

21	nusinersenIBA 01/2023 - 11/2017
18	DystrophinIBA 04/2024 - 08/2012
12	Proteins (Proteins, Gene)FDA Link 04/2023 - 02/2005
10	RisdiplamIBA 05/2024 - 01/2021
9	Nonsense Codon (Nonsense Mutation)IBA 08/2023 - 05/2012
7	Biomarkers (Surrogate Marker)IBA 01/2023 - 01/2019
6	eteplirsenIBA 03/2024 - 02/2016
6	atalurenIBA 08/2023 - 10/2014
6	Antisense OligonucleotidesIBA 01/2023 - 12/2013
5	ZolgensmaIBA 01/2024 - 06/2021
5	Ryanodine Receptor Calcium Release Channel (Ryanodine Receptor)IBA 01/2022 - 12/2004
5	CollagenIBA 12/2013 - 04/2005
4	Adrenal Cortex Hormones (Corticosteroids)IBA 04/2024 - 01/2020
4	Protein Isoforms (Isoforms)IBA 09/2022 - 10/2012
4	DNA (Deoxyribonucleic Acid)IBA 09/2022 - 12/2012
4	Albuterol (Salbutamol)FDA LinkGeneric 01/2019 - 07/2008
4	Dystroglycans (Dystroglycan)IBA 01/2018 - 02/2006
3	RNA Precursors (Precursor, mRNA)IBA 05/2023 - 01/2018
3	domagrozumabIBA 08/2022 - 01/2020
3	golodirsenIBA 01/2022 - 01/2020
3	CalpainIBA 01/2020 - 02/2005
2	givinostatIBA 04/2024 - 10/2016
2	Creatine Kinase (Creatine Phosphokinase)IBA 04/2021 - 10/2012
2	Retinaldehyde (Retinal)IBA 01/2021 - 02/2008
2	olesoximeIBA 12/2020 - 01/2017
2	idebenoneIBA 01/2020 - 05/2015
2	Bevacizumab (Avastin)FDA Link 01/2020 - 01/2018
2	salicylhydroxamic acid (SHAM)IBA 01/2018 - 11/2017
2	TropomyosinIBA 07/2014 - 10/2012
1	VaccinesIBA 01/2024
1	Troponin IIBA 01/2024
1	viltolarsenIBA 01/2023
1	dicarboxydine (DCD)IBA 07/2022
1	Alanine Transaminase (SGPT)IBA 10/2021
1	Complement System Proteins (Complement)IBA 01/2021
1	Biotin (Vitamin H)FDA Link 06/2020
1	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 01/2020
1	Cysteine Proteases (Cysteine Protease)IBA 01/2020

Therapy/Procedure

23	Therapeutics 01/2024 - 12/2013
4	Activities of Daily Living (ADL) 01/2023 - 10/2008
3	Noninvasive Ventilation 01/2019 - 12/2013
2	Lasers (Laser) 01/2020 - 01/2018
2	Sutures (Suture) 01/2017 - 12/2007
1	Physical Therapy Modalities (Physical Therapy Technique) 12/2022
1	Artificial Respiration (Mechanical Ventilation) 06/2022
1	Precision Medicine 01/2022
1	Personal Protective Equipment 12/2021
1	Laminectomy 11/2021
1	Catheters 11/2021
1	Light Coagulation 01/2020